Joanna Góra‐Tybor

1.9k total citations
82 papers, 1.2k citations indexed

About

Joanna Góra‐Tybor is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Joanna Góra‐Tybor has authored 82 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Genetics, 42 papers in Hematology and 21 papers in Pathology and Forensic Medicine. Recurrent topics in Joanna Góra‐Tybor's work include Chronic Lymphocytic Leukemia Research (46 papers), Chronic Myeloid Leukemia Treatments (33 papers) and Lymphoma Diagnosis and Treatment (20 papers). Joanna Góra‐Tybor is often cited by papers focused on Chronic Lymphocytic Leukemia Research (46 papers), Chronic Myeloid Leukemia Treatments (33 papers) and Lymphoma Diagnosis and Treatment (20 papers). Joanna Góra‐Tybor collaborates with scholars based in Poland, Germany and United Kingdom. Joanna Góra‐Tybor's co-authors include Tadeusz Robak, Michael W. Deininger, Junia V. Melo, John M. Goldman, Shikha Bose, Jerzy Z. Błoński, Marek Kasznicki, Krzysztof Jamroziak, Małgorzata Całbecka and L Konopka and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Joanna Góra‐Tybor

74 papers receiving 1.2k citations

Peers

Joanna Góra‐Tybor
Guillermo Garcia‐Manero United States
Liana Gercheva Bulgaria
Michal Bar‐Natan United States
Mirosław Majewski Poland
Karim Maloum France
Jiří Mayer Czechia
Otto Krieger Austria
Anna Turkina Russia
Lorenzo Falchi United States
Vesselina Goranova‐Marinova Bulgaria
Guillermo Garcia‐Manero United States
Joanna Góra‐Tybor
Citations per year, relative to Joanna Góra‐Tybor Joanna Góra‐Tybor (= 1×) peers Guillermo Garcia‐Manero

Countries citing papers authored by Joanna Góra‐Tybor

Since Specialization
Citations

This map shows the geographic impact of Joanna Góra‐Tybor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Góra‐Tybor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Góra‐Tybor more than expected).

Fields of papers citing papers by Joanna Góra‐Tybor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Góra‐Tybor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Góra‐Tybor. The network helps show where Joanna Góra‐Tybor may publish in the future.

Co-authorship network of co-authors of Joanna Góra‐Tybor

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Góra‐Tybor. A scholar is included among the top collaborators of Joanna Góra‐Tybor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Góra‐Tybor. Joanna Góra‐Tybor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Góra‐Tybor, Joanna, et al.. (2024). Professor Euzebiusz Krykowski (3 January 1927–21 March 2024). Acta Haematologica Polonica. 55(2). 60–61. 1 indexed citations
2.
3.
Puła, Bartosz, et al.. (2024). Real-World Outcome and Prognostic Factors in MDS Patients Treated with Azacitidine—A Retrospective Analysis. Cancers. 16(7). 1333–1333. 2 indexed citations
4.
5.
Miłkowska-Dymanowska, Joanna, et al.. (2023). Primary pulmonary Hodgkin’s lymphoma mimicking granulomatosis with polyangiitis – a case report of diagnostic and therapeutic dilemmas. Współczesna Onkologia. 27(2). 113–117.
6.
Canzian, Federico, Joanna Góra‐Tybor, Daniele Campa, et al.. (2022). Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia. Frontiers in Oncology. 12. 952640–952640. 3 indexed citations
7.
Góra‐Tybor, Joanna. (2021). Therapy of Philadelphia-negative myeloproliferative neoplasms in the blast phase. Acta Haematologica Polonica. 52(4). 278–283. 1 indexed citations
8.
Rychter, Anna, et al.. (2017). Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors. Medical Oncology. 34(6). 104–104. 30 indexed citations
9.
10.
Steegmann, J. L., Mauricette Michallet, Enrica Morra, et al.. (2010). A european observational study of dasatinib in the management of imatinib-resistant and -intolerant patients with chronic myeloid leukemia: forte study (ca180-211). 95. 339–339. 1 indexed citations
11.
Góra‐Tybor, Joanna, Krzysztof Jamroziak, Anna Szmigielska‐Kapłon, et al.. (2009). Evaluation of circulating endothelial cells as noninvasive marker of angiogenesis in patients with chronic lymphocytic leukemia. Leukemia & lymphoma. 50(1). 62–67. 14 indexed citations
12.
Robak, Tadeusz, Jerzy Z. Błoński, Ewa Wawrzyniak, et al.. (2008). Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion. Cancer. 115(1). 94–100. 22 indexed citations
13.
Góra‐Tybor, Joanna & Tadeusz Robak. (2008). Targeted Drugs in Chronic Myeloid Leukemia. Current Medicinal Chemistry. 15(29). 3036–3051. 55 indexed citations
14.
Robak, Ewa, Joanna Góra‐Tybor, Radzisław Kordek, et al.. (2005). Richter syndrome first manifesting as cutaneous B-cell lymphoma clonally distinct from primary B-cell chronic lymphocytic leukaemia. British Journal of Dermatology. 153(4). 833–837. 14 indexed citations
15.
Robak, Tadeusz, H Urbańska-Ryś, Joanna Góra‐Tybor, et al.. (2003). Coexistence of Chronic Lymphocytic Leukemia and Essential Thrombocythemia. Leukemia & lymphoma. 44(8). 1425–1431. 9 indexed citations
16.
Robak, Tadeusz, Marek Kasznicki, Joanna Góra‐Tybor, et al.. (2002). Re‐treatment with cladribine‐based regimens in relapsed patients with B‐cell chronic lymphocytic leukemia. European Journal Of Haematology. 69(1). 27–36. 10 indexed citations
17.
Robak, Tadeusz, Jerzy Z. Błoński, Marek Kasznicki, et al.. (2002). Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia. The Hematology Journal. 3(5). 244–250. 38 indexed citations
18.
Robak, Tadeusz, Marek Kasznicki, Joanna Góra‐Tybor, et al.. (2001). Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia. Leukemia. 15(10). 1510–1516. 32 indexed citations
19.
Robak, Tadeusz, Anna Korycka, & Joanna Góra‐Tybor. (1994). The interaction of 2-chlorodeoxy adenosine (2-CDA) and interferon α (IFN-α) on normal and myeloid leukemia hematopoiesis in vitro. Leukemia Research. 18(4). 275–281. 7 indexed citations
20.
Warzocha, Krzysztof, Joanna Góra‐Tybor, M. Kwinkowski, Bożena Szymańska, & Tadeusz Robak. (1994). A comparison of the Antileukaemic Effects of Recombinant HumanTumour Necrosis Factor‐α and its Muteins on Leukaemia L1210 and Leukaemia P388 in Mice. Mediators of Inflammation. 3(6). 411–414. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guillermo Garcia‐Manero Breakdown of academic impact, for papers by Liana Gercheva Breakdown of academic impact, for papers by Michal Bar‐Natan Breakdown of academic impact, for papers by Mirosław Majewski Breakdown of academic impact, for papers by Karim Maloum Breakdown of academic impact, for papers by Jiří Mayer Breakdown of academic impact, for papers by Otto Krieger Breakdown of academic impact, for papers by Anna Turkina Breakdown of academic impact, for papers by Lorenzo Falchi Breakdown of academic impact, for papers by Vesselina Goranova‐Marinova
Rankless by CCL
2026